bioRxiv Immunology's Avatar

bioRxiv Immunology

@biorxiv-immuno.bsky.social

4,989 Followers  |  0 Following  |  4,295 Posts  |  Joined: 24.08.2023  |  1.0519

Latest posts by biorxiv-immuno.bsky.social on Bluesky

Age- and Sex- Driven Transcriptional and Metabolic Diversity in Myeloid-Derived Suppressor Cells After Mouse Sepsis https://www.biorxiv.org/content/10.1101/2025.10.06.680736v1

07.10.2025 21:18 — 👍 0    🔁 0    💬 0    📌 0

Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8+ T cell-macrophage interactions https://www.biorxiv.org/content/10.1101/2025.10.02.680083v1

07.10.2025 14:16 — 👍 0    🔁 0    💬 0    📌 0

Molecular signature of neutrophils in antiphospholipid syndrome based on epigenomic and transcriptome analysis https://www.biorxiv.org/content/10.1101/2025.10.03.680196v1

07.10.2025 14:15 — 👍 0    🔁 0    💬 0    📌 0

Re-infection with SARS-CoV-2 is associated with increased antibody breadth and potency against diverse sarbecovirus strains https://www.biorxiv.org/content/10.1101/2025.10.03.679858v1

07.10.2025 03:16 — 👍 1    🔁 1    💬 0    📌 0

Impaired IFNγ responsiveness of lung monocyte-derived cells limits immunity to Mycobacterium tuberculosis https://www.biorxiv.org/content/10.1101/2025.10.06.680719v1

07.10.2025 02:16 — 👍 1    🔁 2    💬 0    📌 0

Pre-division TCF1 drop determines long-term CD8 T cell fates https://www.biorxiv.org/content/10.1101/2025.10.06.680655v1

07.10.2025 01:16 — 👍 4    🔁 2    💬 0    📌 0

Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design https://www.biorxiv.org/content/10.1101/2025.10.06.680687v1

07.10.2025 01:16 — 👍 0    🔁 0    💬 0    📌 0

Macrophages drive inguinal fat pad and lymph node remodelling in response to peripheral inflammation. https://www.biorxiv.org/content/10.1101/2025.10.06.680668v1

07.10.2025 01:15 — 👍 0    🔁 0    💬 0    📌 0

Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function https://www.biorxiv.org/content/10.1101/2025.10.05.680386v1

07.10.2025 00:16 — 👍 0    🔁 1    💬 0    📌 0

UBA1 Mutations Drive RIPK1-Mediated Cell Death and Monocyte Dysfunction in VEXAS Syndrome https://www.biorxiv.org/content/10.1101/2025.10.06.680650v1

07.10.2025 00:16 — 👍 0    🔁 0    💬 0    📌 0

Adenovirus-based vaccines transduce and activate human Langerhans cells https://www.biorxiv.org/content/10.1101/2025.10.06.680090v1

07.10.2025 00:16 — 👍 0    🔁 1    💬 0    📌 0

A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice https://www.biorxiv.org/content/10.1101/2025.10.06.680344v1

07.10.2025 00:16 — 👍 0    🔁 0    💬 0    📌 0

Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy https://www.biorxiv.org/content/10.1101/2025.10.05.680562v1

06.10.2025 23:16 — 👍 1    🔁 0    💬 0    📌 0

Preselection CD4+CD8+ thymocytes modulate TCR responsiveness following TCRβ selection https://www.biorxiv.org/content/10.1101/2025.10.03.680384v1

06.10.2025 21:15 — 👍 2    🔁 0    💬 0    📌 0

Immunomodulatory Effects of a Cell Processing Device: Insights from Single Cell RNA Sequencing and Gene Set Enrichment Analysis https://www.biorxiv.org/content/10.1101/2025.10.03.680363v1

06.10.2025 17:16 — 👍 0    🔁 0    💬 0    📌 0

Complement activation in maternal and placental pathology of preeclampsia https://www.biorxiv.org/content/10.1101/2025.10.03.680407v1

06.10.2025 14:16 — 👍 0    🔁 0    💬 0    📌 0

Progenitor T cells drive chronic pulmonary type 2 inflammation https://www.biorxiv.org/content/10.1101/2025.10.03.680133v1

06.10.2025 03:15 — 👍 1    🔁 0    💬 0    📌 0

Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection https://www.biorxiv.org/content/10.1101/2025.10.03.680366v1

06.10.2025 02:16 — 👍 0    🔁 0    💬 0    📌 0

Tertiary lymphoid structures support the development of allergen-specific progenitor CD4+ T cells https://www.biorxiv.org/content/10.1101/2025.10.03.680350v1

06.10.2025 02:16 — 👍 3    🔁 1    💬 0    📌 0

Methionine regulates antitumor function of CD8⁺ T cells through polyamine synthesis https://www.biorxiv.org/content/10.1101/2025.10.03.680201v1

05.10.2025 12:15 — 👍 0    🔁 0    💬 0    📌 0

Dynamics of memory B cells and plasmablasts in healthy individuals https://www.biorxiv.org/content/10.1101/2025.10.03.680203v1

05.10.2025 12:15 — 👍 2    🔁 0    💬 0    📌 0

Human immune response to primary cryptosporidiosis parallels murine infection models https://www.biorxiv.org/content/10.1101/2025.10.03.680261v1

05.10.2025 04:16 — 👍 1    🔁 0    💬 0    📌 0

Mucosal vaccine immunity induced by a new auxotrophic Pseudomonas aeruginosa strain is linked to Th17 and IgA responses https://www.biorxiv.org/content/10.1101/2025.10.03.679932v1

05.10.2025 02:16 — 👍 0    🔁 0    💬 0    📌 0

Mechanisms of Differential Signal Transduction by IFNLR1 Variants https://www.biorxiv.org/content/10.1101/2025.10.03.677101v1

05.10.2025 01:15 — 👍 0    🔁 0    💬 0    📌 0

ETV4 restrains the formation of CD74+ cytotoxic exhausted CD8+ T cells https://www.biorxiv.org/content/10.1101/2025.10.02.677509v1

04.10.2025 18:16 — 👍 0    🔁 0    💬 0    📌 0

Atg16l1 promotes lung transplant tolerance by regulating glycolysis in macrophages https://www.biorxiv.org/content/10.1101/2025.10.02.679826v1

04.10.2025 18:15 — 👍 0    🔁 0    💬 0    📌 0

Age-dependent Dysferlin Accumulation in Macrophages Promotes STAT1 Activation via Calcium Influx, Impairing Myogenesis https://www.biorxiv.org/content/10.1101/2025.10.02.679938v1

04.10.2025 18:15 — 👍 0    🔁 0    💬 0    📌 0

Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics https://www.biorxiv.org/content/10.1101/2025.10.03.680253v1

04.10.2025 04:18 — 👍 0    🔁 0    💬 0    📌 0

Discovery of rare antigen-specific TCRs via replicate profiling https://www.biorxiv.org/content/10.1101/2025.09.30.675572v1

04.10.2025 04:18 — 👍 4    🔁 0    💬 0    📌 0

Synthetic signaling platform uncovers and rewires cellular responses to PD-1 perturbation https://www.biorxiv.org/content/10.1101/2025.10.01.679874v1

03.10.2025 21:15 — 👍 0    🔁 1    💬 0    📌 0